For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

Empower, the nation’s second largest 401(k) plan provider, has announced a new program that gives access to participants to ...

These retirement plans meet the legal requirements and the cost for a pre-approved plan is less than for an individually ...

For claims that exceeded the stop-loss deductible by at least $1 million, the average stop-loss claim severity fell 3.8%, to ...

Data is no longer a bystander in employee benefits; it’s driving the way plans are designed, delivered, and measured.

Remote listings in IT and communications surged 100%, while remote listings in education and training went up 20% ...